APELOA CDMO is the contract discovery, development, and manufacturing business of its parent company Apeloa Pharmaceutical Co. Ltd., part of the Hengdian Group, one of the largest private enterprises in China. As a CDMO, we are dedicated to delivering customer APIs, Intermediates, and Regulatory Starting Materials (RSMs). From R&D and scale-up to GMP commercial scale production, Apeloa has proven itself to be a high-quality partner to the global pharmaceutical industry for over 30 years.

APELOA CDMO is a world leader in the development and manufacturing of Active Pharmaceutical Ingredients (APIs), Intermediates, and Starting Materials at virtually any stage. From early-stage development batches to fully commercialized GMP production scales, APELOA CDMO’s highly skilled scientists and engineers deliver tailored custom products to customers from its network of outstandingly modern facilities in China and the US. Our cost-effective CDMO services, in addition to meeting global regulatory and quality standards, are driven by science and customer service, with a strong international footprint.

Below are the CRDMO solutions and services we can provide：

- API Process Development & Manufacturing

- Formulation Development & Manufacturing

- Analytical Development & Quality Control

- Global Regulatory Affairs CMC Filing

- LNP CRDMO services (CLs & ILs / PEG-Lipid)

- PROTAC CRDMO services

- ADC CRDMO services (Payload + Linker)

- Med. Chem

- FTE

Furthermore, we are supporting our chinese biopharma clients to identify licensing opportunities.